The Australian government has officially launched a high-level inquiry into a cybersecurity incident involving OpenAI, marking a watershed moment in…
Read More
Eli Lilly and InnoCare Pharma Forge $3.35bn R&D Partnership to Tackle Oncology and Autoimmune Diseases
Eli Lilly and Company has entered into a sweeping, five-drug research and licensing agreement with China-based biopharmaceutical firm InnoCare Pharma,…
Read More
FDA Approves Eli Lilly’s Once-Weekly Basal Insulin Onswik for Type 2 Diabetes Following Robust Phase III Clinical Trials
The United States Food and Drug Administration has officially granted marketing authorization to Eli Lilly and Company for Onswik, chemically…
Read More
Amberstone, Henlius agree to develop solid-tumour T-cell engagers
Biotechnology innovation continues to push the boundaries of oncology as companies seek safer and more effective ways to harness the…
Read More
Roche Deepens AI and Small Molecule Strategy with Multi-Billion-Dollar Partnerships in Oncology and CVRM
Swiss pharmaceutical giant Roche, acting through its subsidiary Genentech, has entered a blockbuster agreement with Earendil Labs, committing up to…
Read More
US FDA Commissioner Nominee Dr Heidi Overton Defends MMR Vaccine Safety During Contentious Senate Confirmation Hearing
During a high-stakes and politically charged Senate confirmation hearing, Dr Heidi Overton, President Donald Trump’s nominee to lead the US…
Read More
Aptar Pharma and Macquarie University Partner in Three-Year Initiative to Advance Pulmonary Delivery of Biologic Medicines
Drug delivery specialist Aptar Pharma has announced a strategic three-year research collaboration with Macquarie University in Australia, aimed at optimizing…
Read More
Crossroads in the Global Bio-Supply Chain: China Emerges as a Biologic API Manufacturing Hub Amid US Onshoring Push
A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the…
Read More
Made Scientific Expands US East Coast Footprint with Acquisition of Advanced Pennsylvania Cell Therapy Manufacturing Facility from National Resilience
The landscape of advanced therapeutics manufacturing received a significant boost as Made Scientific officially acquired an expansive 85,000-square-foot cell therapy…
Read More
Navigating the Oncology Enrollment Funnel: Why Cancer Clinical Trials Face Protracted Timelines and High Screen Failures
The modern landscape of oncology drug development is characterized by profound scientific breakthroughs, yet it remains perpetually bottlenecked by an…
Read More
